Oral Citicoline in Acute Ischemic Stroke
Open Access
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (12) , 2850-2857
- https://doi.org/10.1161/01.str.0000038691.03334.71
Abstract
Background and Purpose— No single neuroprotective agent has been shown to influence outcome after acute stroke. Citicoline has been studied worldwide in many clinical trials with positive findings,...Keywords
This publication has 8 references indexed in Scilit:
- A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patientsNeurology, 2001
- Current Status and Perspectives of Neuroprotection in Ischemic Stroke TreatmentCerebrovascular Diseases, 2001
- Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imagingAnnals of Neurology, 2000
- Predicting prognosis after strokeNeurology, 2000
- European Stroke Initiative Recommendations for Stroke ManagementCerebrovascular Diseases, 2000
- A randomized dose-response trial of citicoline in acute ischemic stroke patientsNeurology, 1997
- Practical methodology of meta‐analyses (overviews) using updated individual patient dataStatistics in Medicine, 1995
- Meta-Analysis in Clinical ResearchAnnals of Internal Medicine, 1987